Top Markets
Coin of the day
ProUroCare Medical Inc. ProUroCare Medical Inc.

ProUroCare Medical Inc.

PUMD
Rang in aandelen #42361
ProUroCare Medical Inc. is dedicated to developing advanced products for the... ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$1.86K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-50.00%
Land
US
Handel ProUroCare Medical Inc. (PUMD)

Categorie

P/S-ratio voor ProUroCare Medical Inc. (PUMD)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van ProUroCare Medical Inc. is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor ProUroCare Medical Inc. van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
3.95 -
US
4.83 -
US
2.78 -
IE
3.31 -
US
7.61 -
US